期刊
ADVANCED FUNCTIONAL MATERIALS
卷 26, 期 15, 页码 2463-2472出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adfm.201504070
关键词
drug and gene delivery; in vivo imaging; nanoparticle; stem cell differentiation
类别
资金
- Research Grants Council of Hong Kong [439913]
- Shun Hing Institute of Advanced Engineering, The Chinese University of Hong Kong [BME-p3-15]
- National Natural Science Foundation of China [31570979]
- Chow Yuk Ho Technology Centre for Innovative Medicine, The Chinese University of Hong Kong
Cartilage loss is a leading cause of disability among adults, and effective therapy remains elusive. Human mesenchymal stem cells (hMSCs), which have demonstrated self-renewal and multipotential differentiation, are a promising cell source for cartilage repair. However, the hypertrophic differentiation of the chondrogenically induced MSCs and resulting tissue calcification hinders the clinical translation of MSCs for cartilage repair. Here, a multifunctional nanocarrier based on quantum dots (QDs) is developed to enhance chondrogenic differentiation and suppress hypertrophy of hMSCs simultaneously. Briefly, the QDs are modified with beta-cyclodextrin (beta-CD) and RGD peptide. The resulting nanocarrier is capable of carrying hydrophobic small molecules such as kartogenin in the hydrophobic pockets of conjugated beta-CD to induce chondrogenic differentiation of hMSCs. Meanwhile, via electrostatic interaction the conjugated RGD peptides bind the cargo siRNA targeting Runx2, which is a key regulator of hMSC hypertrophy. Furthermore, due to the excellent photostability of QDs, hMSCs labeled with the nanocarrier can be tracked for up to 14 d after implantation in nude mice. Overall, this work demonstrates the potential of our nanocarrier for inducing and maintaining the chondrogenic phenotype and tracking hMSCs in vivo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据